News

Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores

BOULDER, CO / ACCESSWIRE / May 9, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing…

5 months ago

Mediprogen Has Entered Into Commercial Discussions With Moolec to Expand Their Technology Into the Cosmetics Global Market

PYEONGCHANG, SOUTH KOREA / ACCESSWIRE / May 9, 2024 / Mediprogen Inc., a company that produces purified protein for the…

5 months ago

Mediprogen Has Entered Into Commercial Discussions With Moolec to Expand Their Technology Into the Cosmetics Global Market

PYEONGCHANG, SOUTH KOREA / ACCESSWIRE / May 9, 2024 / Mediprogen Inc., a company that produces purified protein for the…

5 months ago

Poolbeg Pharma PLC Announces Annual Report & AGM Notice

LONDON, UK / ACCESSWIRE / May 9, 2024 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), 'Poolbeg' or the 'Company'), a biopharmaceutical company focussed on…

5 months ago

Poolbeg Pharma PLC Announces Annual Report & AGM Notice

LONDON, UK / ACCESSWIRE / May 9, 2024 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), 'Poolbeg' or the 'Company'), a biopharmaceutical company focussed on…

5 months ago

Asia Green Biotechnology Corp. Announces Grant of Application for Management Cease Trade Order

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESCALGARY, AB / ACCESSWIRE / May 8, 2024…

5 months ago

Asia Green Biotechnology Corp. Announces Grant of Application for Management Cease Trade Order

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESCALGARY, AB / ACCESSWIRE / May 8, 2024…

5 months ago

Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024

DENVER, CO / ACCESSWIRE / May 8, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company…

5 months ago

Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024

DENVER, CO / ACCESSWIRE / May 8, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company…

5 months ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024

Reports Net Revenues of $171.8 Million for the Three Months Ended March 31, 2024 RANCHO CUCAMONGA, CA / ACCESSWIRE /…

5 months ago